Issue Information
6 June 2018
Treatment of the extrahepatic manifestations of chronic hepatitis C infection
Karn Wijarnpreecha, Wisit Cheungpasitporn, Surakit Pungpapong, Kiran R. Nakkala – 5 June 2018
CON (“The window is closed”): In patients with cirrhosis with ascites, the clinical risks of nonselective beta‐blocker outweigh the benefits and should NOT be prescribed
Ariel W. Aday, Nicole E. Rich, Arjmand R. Mufti, Shannan R. Tujios – 5 June 2018
Risk factors, scoring systems, and interventions for alcohol relapse after liver transplantation for alcoholic liver disease
Jane Lim, Vinay Sundaram – 5 June 2018
Hepatic fibrosis: Avenues of investigation and clinical implications
Jessica E.S. Shay, James P. Hamilton – 5 June 2018
PRO (“The Window Is Open”): In patients with cirrhosis with prior variceal hemorrhage and ascites, the clinical benefits of nonselective beta‐blockers outweigh the risks and should be prescribed
Danielle Tholey, Nitzan Roth, Thomas Schiano – 5 June 2018
Imaging of abnormal liver function tests
Saivenkat H. Vagvala, Stacy D. O'Connor – 5 June 2018
Treatment of the extrahepatic manifestations of chronic hepatitis C infection
Karn Wijarnpreecha, Wisit Cheungpasitporn, Surakit Pungpapong, Kiran R. Nakkala – 5 June 2018
Issue Information
1 June 2018
Hepatitis B Virus–Upregulated LNC‐HUR1 Promotes Cell Proliferation and Tumorigenesis by Blocking p53 Activity
Ningning Liu, Qi Liu, Xiaohai Yang, Fang Zhang, Xinda Li, Yuanwu Ma, Feifei Guan, Xin Zhao, Zhiwei Li, Lianfeng Zhang, Xin Ye – 23 May 2018 – Recent studies have indicated that a number of long noncoding RNAs (lncRNAs) are dysregulated in hepatocellular carcinoma, while their aberrant expressions are associated with tumorigenesis and poor prognosis. To identify hepatitis B virus (HBV)‐related lncRNAs, we used RNA deep sequencing to quantify the abundances of lncRNAs in HepG2 cells and HBV transgenic HepG2‐4D14 cells.